Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022. Clin Breast Cancer. 2020 04; 20(2):145-151.e2.
View in:
PubMed
subject areas
Administration, Oral
Administration, Oral
Adult
Adult
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Brain
Brain
Brain Neoplasms
Brain Neoplasms
Breast
Breast
Breast Neoplasms
Breast Neoplasms
Chemotherapy, Adjuvant
Chemotherapy, Adjuvant
Craniotomy
Craniotomy
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Middle Aged
Middle Aged
Neoadjuvant Therapy
Neoadjuvant Therapy
Pilot Projects
Pilot Projects
Quinolines
Quinolines
Receptor, ErbB-2
Receptor, ErbB-2
Tissue Distribution
Tissue Distribution
Treatment Outcome
Treatment Outcome
authors with profiles
Ian F Dunn